Skip to main content
PRCT logo
PRCT
(NASDAQ)
PROCEPT BioRobotics Corporation
$25.12-- (--)
Loading... - Market loading

PROCEPT BioRobotics Corporation (PRCT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for PROCEPT BioRobotics Corporation stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
High Confidence3.5:1 Buy/Sell

Average Price Target

$28.40
13.06% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PRCT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

David Rescott
Baird
HoldInitiates
$30.00
Matthew O'Brien
Piper Sandler
BuyMaintains
$28.00
Richard Newitter
Truist
Strong BuyMaintains
$47.00 $30.00
Danielle Antalffy
UBS
BuyMaintains
$62.00 $30.00
Stephanie Piazzola
BofA Securities
SellReiterates
$20.00
Matt O'Brien
Piper Sandler
BuyMaintains
$50.00 $28.00
Ryan Zimmerman
BTIG
HoldMaintains
-
Mike Kratky
Leerink Partners
BuyMaintains
$55.00 $30.00
Joshua Jennings
TD Cowen
Strong BuyMaintains
$50.00 $34.00
Craig Bijou
BofA Securities
SellDowngrades
$38.00 $20.00
Nathan Treybeck
Wells Fargo
BuyMaintains
$51.00 $34.00
Suraj Kalia
Oppenheimer
HoldDowngrades
-

Frequently Asked Questions

What is the analyst consensus rating for PRCT?

The analyst consensus rating for PRCT is "Buy" based on 12 analyst recommendations.

What is the average price target for PRCT?

The average 12-month price target for PRCT is $28.40, representing an upside of 13.1% from the current price of $25.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.